Good news on the health front.  Just a few weeks ago, I reported positive test results on a DNA procedure for sickle cell anemia.  And now it is available.  Do not know cost, or what must be done to get a prescription (or insurance coverage etc), but this treatment looks promising and addresses the type of  condition that CRISPR DNA/MRNA teck was designed for.

Yesterday, the Food and Drug Administration APPROVED for the first-ever drug based CRISPR gene-editing technology, marking a significant milestone in medical science. This innovative therapy, known as Casgevy, is designed to treat sickle cell disease and offers a potential cure for individuals afflicted with this chronic, life-limiting blood disorder. Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, Casgevy’s approval represents a major scientific victory for gene-editing technology, which allows for accurate and effective correction of DNA mutations. This breakthrough paves the way for a new generation of genetic treatments for hereditary conditions. (Source: statnews. com)